CASSS – Sharing Science Solutions’ Post

If you are a scientist and/or regulator interested in cell and gene therapy therapy products, this is a must-attend meeting. Don't take my word for it. Instead, read what some of last year's attendees wrote: "Great discussions, good case studies, very relevant" "Very useful conference - a must attend" and "Authentic case studies, presented by people with firsthand experience."

FabRICATOR used in an Capillary Gel Electrophoresis application - I will of course listen to this webinar. Why don't you sign up as well :-) #CapillaryElectrophoresis #FabRICATOR #SmartEnzymes

At the latest #ISOQOL conference, Dana DiBenedetti, PhD, Vice President of Patient-Centered Outcomes Assessment presented information on Innovations in in-trial interviews: novel approaches to capturing the patient experience in quality of life research. Read more about those approaches here: https://ow.ly/mkE350PVeOU #HCQoL #patientvoice #clinicianreported #patientcentered #biopharmaceuticals #drugdevelopment

🎉 Congratulations #IMBiologics! 🎉 We are thrilled to share the exciting news that our client, IMBiologics, has signed a licensing-out (L/O) agreement with Navigator Medicines for 'IMB-101,' a bispecific antibody-based treatment currently in Phase 1 clinical trials targeting autoimmune diseases. #ProBio played a pivotal role in this project by providing a comprehensive suite of #CMC development and #IND dossier services, supporting IMBiologics in obtaining #FDA clearance and achieving a smooth license-out. This strategic partnership marks a significant milestone in the journey towards innovative treatments and showcases the dedication and hard work of both the IMBiologics and ProBio teams. We look forward to seeing the positive impact 'IMB-101' will have on patients worldwide. For more details, please visit: https://lnkd.in/eDqYjYMX #LifeSciences #Biotechnology #Pharma #AutoimmuneDiseases #Innovation #IMBiologics #NavigatorMedicines #IMB-101 #Bispecific #Antibody #Collaboration

What are you waiting for??? Register now for this combination of Summit and Symposium on Cell and Gene therapy. A great way to be part of in depth CMC Regulatory discussions in the presence of regulators from global agencies to help shape and accelerate the field! #CGTP2024

On Monday, April 8, at 8 a.m. ET, we will host a conference call and webcast to share topline data from our ongoing Phase 1/2 clinical trials of INZ-701 in adults with #ENPP1 Deficiency and #ABCC6 Deficiency.    Our leadership team will also provide an update on our Natural History Study in pediatric patients with ABCC6 Deficiency and will be joined by key opinion leaders who will present an overview of the unmet need in ABCC6 Deficiency.     Learn more about how to join: https://bit.ly/3xbweBF     #RareDisease #Biotech #Biopharmaceutical 

Download our #whitepaper, “Freezing Rate Controlled Validation,” to better understand how controlled rate freezing for #biopharmaceuticals can be achieved and how the effect of load and container position effects freeze rates. Get your copy here 📩 https://lnkd.in/eEnGCMr5

What lies ahead for Nanexa? Join CEO David Westberg & CFO Björn Svanström as they take a wide range of questions on everything from projects to partnerships from a panel of expert analysts. Watch the Q&A (in Swedish, with some questions in English) HERE: https://lnkd.in/d-ehPMMW #diabetes #multiplemyeloma #drugformulation #drugdelivery #drugdevelopment #pharmacetuicals #biopharmaceuticals #longactinginjectables #monoclonalantibodies #longactingmonoclonalantibodies

In our latest collaborative application note with Analytik Jena, we present the Microsart®️ ATMP Mycoplasma Assay's integration with the qTOWER iris 96 and 384 systems. This documentation provides insights into the assay's adherence to European Pharmacopoeia standards for mycoplasma testing. Key findings include: 🔍 Quantitative PCR allows for precise genomic copy number determination. 📈 The assay demonstrates consistent PCR efficiency and homogeneity across replicates. 🧪 Comparative analysis between qTOWER iris 96 and 384 models indicates suitability for high-throughput applications. Learn more: https://ow.ly/xKPZ50So7bL #Mycoplasma #CellTherapeutics #qPCR #Biopharmaceutical #QualityAssurance #Sartorius #AnalytikJena #QualityControl

Within the ever-shifting domain of pharmaceutical research and development, there is a continual need to underscore the value of preserving the precision and relevance of an Investigator Brochure. This case study takes you deep into a pivotal task: the thorough refinement of an Investigator Brochure tailored for a groundbreaking investigational product, meticulously crafted to address respiratory diseases. Here, we will explore the nuances, obstacles, and moments of success encountered by a resolute team of experts devoted to advancing healthcare through exacting scientific exploration. View more………..https://lnkd.in/dNWkBMSd